Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson’s disease: relationship to clinical data
- 1 November 1999
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 170 (2) , 90-95
- https://doi.org/10.1016/s0022-510x(99)00192-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- Scavenging Effects of Dopamine Agonists on Nitric Oxide RadicalsJournal of Neurochemistry, 1996
- Origin and functional consequences of the complex I defect in Parkinson's diseaseAnnals of Neurology, 1996
- Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fractionEuropean Journal of Pharmacology, 1996
- Neutrophil function, nitric oxide, and blood oxidative stress in Parkinson's diseaseMovement Disorders, 1996
- Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal gangliaAnnals of Neurology, 1994
- Antioxidant Properties of Bromocriptine, a Dopamine AgonistJournal of Neurochemistry, 1994
- Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromesBrain, 1993
- Pergolide can induce soluble Superoxide dismutase in rat striataJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- ParkinsonismNeurology, 1967